First-Line Ribociclib Plus Endocrine Therapy Versus Chemotherapy With or Without Subsequent Endocrine Therapy in Patients With Rapidly Progressive HR-Positive/HER2-Negative Advanced Breast Cancer
Clinical trial NCT06375707 · COMPLETED
Trial details
- NCT number
- NCT06375707
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-09
- Primary completion
- 2026-05-30
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.